Follow
PETER BAILEY
PETER BAILEY
Botton-Champalimaud Pancreatic Cancer Center
Verified email at glasgow.ac.uk
Title
Cited by
Cited by
Year
Genomic analyses identify molecular subtypes of pancreatic cancer
P Bailey, DK Chang, K Nones, AL Johns, AM Patch, MC Gingras, ...
Nature 531 (7592), 47-52, 2016
31742016
Whole genomes redefine the mutational landscape of pancreatic cancer
N Waddell, M Pajic, AM Patch, DK Chang, KS Kassahn, P Bailey, ...
Nature 518 (7540), 495-501, 2015
26452015
The repertoire of mutational signatures in human cancer
LB Alexandrov, J Kim, NJ Haradhvala, MN Huang, AW Tian Ng, Y Wu, ...
Nature 578 (7793), 94-101, 2020
23832020
Integrated genomic characterization of pancreatic ductal adenocarcinoma
BJ Raphael, RH Hruban, AJ Aguirre, RA Moffitt, JJ Yeh, C Stewart, ...
Cancer cell 32 (2), 185-203. e13, 2017
15182017
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
15062020
Whole–genome characterization of chemoresistant ovarian cancer
AM Patch, EL Christie, D Etemadmoghadam, DW Garsed, J George, ...
Nature 521 (7553), 489-494, 2015
14762015
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
VP Balachandran, M Łuksza, JN Zhao, V Makarov, JA Moral, R Remark, ...
Nature 551 (7681), 512-516, 2017
9862017
The evolutionary history of 2,658 cancers
M Gerstung, C Jolly, I Leshchiner, SC Dentro, S Gonzalez, D Rosebrock, ...
Nature 578 (7793), 122-128, 2020
8472020
Whole-genome landscape of pancreatic neuroendocrine tumours
A Scarpa, DK Chang, K Nones, V Corbo, AM Patch, P Bailey, RT Lawlor, ...
Nature 543 (7643), 65-71, 2017
8382017
CXCR2 inhibition profoundly suppresses metastases and augments immunotherapy in pancreatic ductal adenocarcinoma
CW Steele, SA Karim, JDG Leach, P Bailey, R Upstill-Goddard, L Rishi, ...
Cancer cell 29 (6), 832-845, 2016
7542016
Molecular subtypes of pancreatic cancer
EA Collisson, P Bailey, DK Chang, AV Biankin
Nature reviews Gastroenterology & hepatology 16 (4), 207-220, 2019
7222019
Patterns of somatic structural variation in human cancer genomes
Y Li, ND Roberts, JA Wala, O Shapira, SE Schumacher, K Kumar, ...
Nature 578 (7793), 112-121, 2020
6922020
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
E Rheinbay, MM Nielsen, F Abascal, JA Wala, O Shapira, G Tiao, ...
Nature 578 (7793), 102-111, 2020
5012020
Arrays of ultraconserved non-coding regions span the loci of key developmental genes in vertebrate genomes
A Sandelin, P Bailey, S Bruce, PG Engström, JM Klos, WW Wasserman, ...
BMC genomics 5, 1-9, 2004
3812004
Epithelial NOTCH signaling rewires the tumor microenvironment of colorectal cancer to drive poor-prognosis subtypes and metastasis
R Jackstadt, SR van Hooff, JD Leach, X Cortes-Lavaud, JO Lohuis, ...
Cancer cell 36 (3), 319-336. e7, 2019
3032019
Genomic basis for RNA alterations in cancer
PCAWG Transcriptome Core Group Calabrese Claudia 2 Davidson Natalie R. 3 4 5 ...
Nature 578 (7793), 129-136, 2020
302*2020
Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis
K Nones, N Waddell, N Wayte, AM Patch, P Bailey, F Newell, O Holmes, ...
Nature communications 5 (1), 5224, 2014
2962014
A dynamic role for HDAC7 in MEF2-mediated muscle differentiation
U Dressel, PJ Bailey, SCM Wang, M Downes, RM Evans, GEO Muscat
Journal of Biological Chemistry 276 (20), 17007-17013, 2001
2782001
Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy
BW Miller, JP Morton, M Pinese, G Saturno, NB Jamieson, E McGhee, ...
EMBO molecular medicine 7 (8), 1063-1076, 2015
2682015
Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers
JD French, M Ghoussaini, SL Edwards, KB Meyer, K Michailidou, ...
The American Journal of Human Genetics 92 (4), 489-503, 2013
2532013
The system can't perform the operation now. Try again later.
Articles 1–20